A phase II trial of gemcitabine plus capecitabine for patients with advanced pancreatic adenocarcinoma.
Park BB, Park JO, Lee HR, Lee J, Choi DW, Choi SH, Heo JS, Lee JK, Lee KT, Lim DH, Park YS, Lim HY, Kang WK, Park K.
Park BB, et al. Among authors: lim dh, lim hy.
Cancer Chemother Pharmacol. 2007 Sep;60(4):489-94. doi: 10.1007/s00280-006-0390-7. Epub 2007 Mar 30.
Cancer Chemother Pharmacol. 2007.
PMID: 17396266
Clinical Trial.